News Daily News Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke Todd Neale July 29, 2019
News Daily News FDA Grants Cardiac MR Indication for Gadavist Contrast Injection Shelley Wood July 16, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
News Daily News TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps Yael L. Maxwell June 11, 2019
News Conference News SCAI 2019 ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3 Yael L. Maxwell June 05, 2019
News Conference News EAS 2019 CHD Mortality Significantly Elevated in Patients With Severe FH Michael O'Riordan May 29, 2019
News Conference News EuroPCR 2019 New Clarity on Patients at High Risk for Bleeding After PCI Michael O'Riordan May 28, 2019
News Conference News ESC Heart Failure 2019 Device-Based Therapy Offers REPRIEVE From Decongestion in Acute HF: TARGET 1 and 2 Shelley Wood May 25, 2019
News Daily News Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations L.A. McKeown April 23, 2019
News Conference News ACC 2019 New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead Michael O'Riordan March 17, 2019
News Daily News HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR L.A. McKeown March 13, 2019
News Daily News Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth Todd Neale March 05, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Breast Calcifications May Hold Important Clues for CV Risk Stratification L.A. McKeown February 22, 2019
News Daily News Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI L.A. McKeown January 31, 2019
News Daily News African-American ACS Patients Less Often Treated With Prasugrel After PCI Yael L. Maxwell January 24, 2019
News Daily News Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review Caitlin E. Cox January 11, 2019
News Daily News Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions Yael L. Maxwell January 02, 2019